NEW YORK (Reuters)—Individuals fully inoculated against COVID-19 can meet in small groups with other vaccinated people without wearing masks, but should keep wearing them outside the home, the U.S. Centers for Disease Control and Prevention (CDC) said on March 8. CDC Director Rochelle Walensky, MD, MPH, said during a briefing that the agency’s new guidance…
State-of-the-Art Clinical Symposium Premeeting Courses Feature Billing, Coding & Insurance Opportunities
Courses before the 2021 State-of-the-Art Clinical Symposium will focus heavily on what’s new in practice, including mastering evaluation and management changes and access to treatments in rheumatology. Early bird registration ends March 31.
ACR, Coalition Ask Congress to Fund Pediatric Subspecialty Loan Repayment Program
The ACR has joined with a coalition of organizations dedicated to improving the health and wellbeing of children and adolescents to request $50 million to fund the Pediatric Subspecialty Loan Repayment Program.
Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks
In Canada, a subcutaneous formulation of CT-P13, which is biosimilar to infliximab, was approved to treat rheumatoid arthritis.
Thank You to Our 2020 Authors
The editors of The Rheumatologist would like to thank all of the rheumatologists, rheumatology professionals and professional writers who took the time and effort in an unprecedented pandemic year to ensure we could continue to bring you the important clinical guidelines, case reports, current research, COVID-19 coverage and so much more. This publication would not…
Modern Treatment Tied to Low Disease Activity in Pregnant RA Patients
(Reuters Health)—Many pregnant women with rheumatoid arthritis (RA) may achieve low disease activity in the third trimester with a modern treatment regimen that includes anti-tumor necrosis factor (TNF) medications, a recent study suggests. Researchers examined data on 309 patients with RA who were pregnant or trying to conceive and who were treated with modern treat-to-target…
Race Matters in COVID-19 Outcomes for Patients with Rheumatic Disease
COVID-19-related deaths are significantly higher in communities with higher proportions of Black, Latinx, Asian American or other racial/ethnic minorities.
Reassuring Data on Immune Checkpoint Inhibitors in Autoimmune Disease
NEW YORK (Reuters Health)—Patients with preexisting autoimmune disease (AIDs) are not at increased risk for immune-related adverse events from immune checkpoint inhibitor (ICI) therapy, although these adverse events may be more likely in patients with inflammatory bowel disease (IBD), new research indicates. “Therefore, we encourage physicians not to withhold ICI in most common AIDs. However,…
CDC-Funded RISE Project Aims to Improve Systemic Lupus Erythematosus Patient Outcomes
In September 2020, the ACR received a $7 million grant for a four-pronged SLE approach that seeks to address gaps and inequities in SLE through physician education, medical school outreach, pediatric support and disease management.
Immunosuppressive Medicines Do Not Worsen COVID-19 Outcomes
(Reuters)—Medications that suppress the immune system—necessary for many chronic diseases—do not worsen outcomes of COVID-19 cases, new data suggest. Researchers looked back at 2,121 adults hospitalized for COVID-19 between March and August, including 108 who were taking immunosuppressive drugs (primarily prednisone, tacrolimus or mycophenolate mofetil). After accounting for patients’ general baseline health status, researchers found…
- « Previous Page
- 1
- …
- 81
- 82
- 83
- 84
- 85
- …
- 332
- Next Page »